An innovative gene editing company discovering and developing curative treatments for genetic diseases
Casebia Therapeutics is a pioneering biotechnology company dedicated to discovering, developing, and commercializing innovative gene-editing therapeutics. Focused on curing genetic diseases, Casebia Therapeutics leverages cutting-edge CRISPR-Cas9 technology and protein engineering expertise to develop breakthrough treatments for blood disorders, blindness, and congenital heart disease.
Operating from its primary location at 610 Main Street, CAMBRIDGE, MA 02139, US, and also at 455 Mission Bay Blvd South, San Francisco, CA 94158, US, Casebia Therapeutics is committed to advancing medical breakthroughs. The company’s work is centered on creating effective and patient-focused solutions to address critical unmet needs in ophthalmology and hematology.
Casebia Therapeutics is at the forefront of scientific innovation, consistently striving to make a significant impact on human health through gene-editing technology. We invite the manager of Casebia Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight your groundbreaking work.
Compare Casebia Therapeutics with 3 companies in Biotechnology
| Comparison Field |
Casebia TherapeuticsMain Company |
Al
Alkeus Pharmaceutica...View Profile |
PharmaEssentiaView Profile |
Xcene ResearchView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2010 | 2003 | 2015 |
|
Company Size
|
— | 11-50 | 201-500 | 51-200 |
|
City
|
CAMBRIDGE, MA | Cambridge, MA | Burlington, MA | Ikeja , Lagos |
|
Country
|
United States | United States | United States | |
|
Skills & Keywords
Comparing with main company
|
18 Total Skills
CRISPR-Cas9
gene editing
biotechnology
genetic diseases
protein engineering
ophthalmology
hematology
CRISPR-Cas9 gene editing technology
Protein Engineering
Medical Breakthroughs
Genetic Diseases
Scientific Innovation
Rare Disease
Breakthrough Human Therapeutics
Patient Focused
Ophthalmology
Gene-editing technology
Hematology
|
3 Total
3 Unique
Unique Skills:
Biopharmaceuticals
Inherited Retinal Disorders
Retina
|
6 Total
6 Unique
Unique Skills:
Biologics
Drug Development
Oncology
Orphan Disease
Orphan Drugs
Pharmaceuticals
|
19 Total
19 Unique
Unique Skills:
Cardiovascular
CNS
Dermatology
Diabetes
Endocrinology & Metabolism
GI
+13
|
Other organizations in the same industry
This company is also known as